| |
| Device | Vercise Deep Brain Stimulation (DBS) System |
| Generic Name | Stimulator, electrical, implanted, for parkinsonian symptoms |
| Applicant | Boston Scientific Corp 25155 Rye Canyon Loop Valencia, CA 91355 |
| PMA Number | P150031 |
| Supplement Number | S028 |
| Date Received | 12/30/2019 |
| Decision Date | 12/29/2020 |
| Product Code |
NHL |
| Docket Number | 20M-2367 |
| Notice Date | 01/27/2021 |
| Advisory Committee |
Neurology |
| Supplement Type | Panel Track |
| Supplement Reason | Labeling Change - Indications/instructions/shelf life/tradename |
| Expedited Review Granted? | No |
| Combination Product | No |
| Predetermined Change Control Plan Authorized | No |
Approval Order Statement Approval for the Vercise PC and Vercise Gevia DBS Systems for expanding the indications to include bilateral stimulation of the internal globus pallidus (GPi) as an adjunctive therapy to reduce some of the symptoms of advanced levodopa-responsive Parkinsons disease that is not adequately controlled by medications. |
| Approval Order | Approval Order |
| Summary | Summary of Safety and Effectiveness |
| Labeling | Labeling Labeling Part 2 |